Tags

Type your tag names separated by a space and hit enter

[Therapy of severe migraine attacks: practical tips].
MMW Fortschr Med. 2005 May 17; 147 Spec No 2:21-2, 24-6.MF

Abstract

Severe migraine attacks are treated with triptans. The forms of administration of the active substances depend on the drug profile. A standard therapy does not exist. The rate of side effects is low. Triptans are contraindicated for patients with coronary, cerebral and peripheral vascular diseases. Under no circumstances are they to be combined with ergot alkaloids. Triptans are all the more effective, the earlier they are taken. For determining the optimal time point for taking the medication, the so-called triptan threshold is helpful. Triptans are not suitable for treating status migrainosus. Sumatriptan can be administered electively and in compliance with the contraindications for the emergency treatment.

Authors+Show Affiliations

Göbel H
Neurologisch-verhaltensmedizinische Schmerzklinik Kiel. kiel@schmerzklinik.de

MeSH

AnalgesicsAntiemeticsCombined Modality TherapyDose-Response Relationship, DrugDrug Administration RoutesDrug Administration ScheduleDrug Therapy, CombinationHumansMigraine DisordersSumatriptanTreatment OutcomeVasoconstrictor Agents

Pub Type(s)

Comparative Study
English Abstract
Journal Article

Language

ger

PubMed ID

15968868

Citation

Göbel, Hartmut. "[Therapy of Severe Migraine Attacks: Practical Tips]." MMW Fortschritte Der Medizin, vol. 147 Spec No 2, 2005, pp. 21-2, 24-6.
Göbel H. [Therapy of severe migraine attacks: practical tips]. MMW Fortschr Med. 2005;147 Spec No 2:21-2, 24-6.
Göbel, H. (2005). [Therapy of severe migraine attacks: practical tips]. MMW Fortschritte Der Medizin, 147 Spec No 2, 21-2, 24-6.
Göbel H. [Therapy of Severe Migraine Attacks: Practical Tips]. MMW Fortschr Med. 2005 May 17;147 Spec No 2:21-2, 24-6. PubMed PMID: 15968868.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Therapy of severe migraine attacks: practical tips]. A1 - Göbel,Hartmut, PY - 2005/6/23/pubmed PY - 2005/12/13/medline PY - 2005/6/23/entrez SP - 21-2, 24-6 JF - MMW Fortschritte der Medizin JO - MMW Fortschr Med VL - 147 Spec No 2 N2 - Severe migraine attacks are treated with triptans. The forms of administration of the active substances depend on the drug profile. A standard therapy does not exist. The rate of side effects is low. Triptans are contraindicated for patients with coronary, cerebral and peripheral vascular diseases. Under no circumstances are they to be combined with ergot alkaloids. Triptans are all the more effective, the earlier they are taken. For determining the optimal time point for taking the medication, the so-called triptan threshold is helpful. Triptans are not suitable for treating status migrainosus. Sumatriptan can be administered electively and in compliance with the contraindications for the emergency treatment. SN - 1438-3276 UR - https://www.unboundmedicine.com/medline/citation/15968868/[Therapy_of_severe_migraine_attacks:_practical_tips]_ DB - PRIME DP - Unbound Medicine ER -